- Filed
- May 5, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 28, 2026 | 187.12M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 196.82M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 175.38M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $3.37M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $3.47M |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $84.42M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $78.87M |
| Capex | Q1 2026 · Mar 31, 2026 | $19K |
| Capex | Q1 2026 · Mar 31, 2025 | $8K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$230.63M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$222.2M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $2.54B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $2.29B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $42.37M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $56.99M |
| Cash And Equivalents restated | Q1 2026 · Mar 31, 2025 | $51.16M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.23B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.22B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $2B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $1.99B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.6B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.37B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $4.83B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.58B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.23 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.29 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.23 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.29 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $4.8M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $4.81M |
| Net Income | Q1 2026 · Mar 31, 2026 | $42.5M |
| Net Income | Q1 2026 · Mar 31, 2025 | $50.34M |